Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

November 1, 2024

Conditions
Acute Mesenteric IschemiaSepsis BacterialIntra-abdominal InfectionDigestive Inflammation
Interventions
DEVICE

Septicyte Lab Test pre operative

"SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response.~Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively."

DEVICE

Septicyte Lab Test post operative

"SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response.~Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively."

Trial Locations (1)

54500

CHRU de Nancy, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06507423 - Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia | Biotech Hunter | Biotech Hunter